Analytical Data
-
基因名
GALP
- Application
-
别名
GALP；Galanin-like peptide
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UBC7
-
表达区间
25-84aa
-
氨基酸序列
APAHRG RGGWTLNSAG YLLGPVLHLP QMGDQDGKRE TALEILDLWK AIDGLPYSHP PQPS
-
分子量
12.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GALP (Galanin-like peptide) is a neuropeptide that has gained attention in the field of biomedical research due to its involvement in several physiological processes, including appetite regulation, energy homeostasis, and stress responses. Originating from the hypothalamus, GALP interacts with galanin receptors, influencing neuroendocrine functions and potentially serving as a target for obesity and metabolic disorder treatments. Research on GALP is pivotal as it provides insights into its roles in neurobiology and metabolic regulation. The structural characteristics and conformational dynamics of GALP, as well as its interaction with receptors, are crucial for understanding its functional mechanisms. Recombinant GALP production allows scientists to study its properties in a controlled environment, enabling investigations into its pharmacological applications. Understanding the structure-function relationship of GALP can lead to the discovery of novel therapeutic approaches for obesity and related metabolic conditions. As research progresses, the potential of GALP as a biomarker or therapeutic target may unveil new pathways for treating metabolic disorders and improving health outcomes.
